The report lists Eternal as a Focus Investment Idea with a Buy rating, CMP Rs 320 and target Rs 430, implying 34% upside over a 1-year horizon.
Read this note →Research notes
What India's research desks published, reported with attribution and linked to the original notes. Orivam issues no recommendations of its own.
258 notes from Motilal Oswal · 01 Oct 2026, 00:00 to 01 Nov 2026, 00:00 IST
The report recommends BUY on Divis Laboratories at CMP ₹9,540 with target ₹10,800 and stop-loss ₹8,870, citing peptide API demand growth, favorable US tariff clarity, and expected 21% earnings CAGR over FY26-28.
Read this note →The report rates GE Vernova T&D India BUY with CMP INR 4,201 and target INR 5,100, citing India's transmission investment cycle, order book above Rs 300bn, and expected revenue/EBITDA/PAT CAGR of 26%/24%/24% over FY26-29E.
Read this note →The report rates LG Electronics India BUY with CMP INR 1,711 and target INR 2,080, citing double-digit growth across TV, washing machine and AC categories, an AC price hike, premiumization and Sri City capacity expansion.
Read this note →The report states Bluedart Express is set to increase prices by 9-12% effective January 2027, viewed positively.
Read this note →The report notes Aurobindo Pharma's subsidiary Acrotech Biopharma launched ADQUEY ointment in the US, marking its entry into US dermatology market, viewed positively.
Read this note →The report states ACC has commissioned a 2.4 MTPA grinding unit in Uttar Pradesh and added 1 MTPA blending capacity in Maharashtra, taking combined capacity to 3.4 MTPA, viewed positively.
Read this note →The report notes L&T's Transportation Infrastructure vertical secured twin contracts worth Rs 30,000 cr from Dubai's RTA and views this positively.
Read this note →